Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate 2021-03-24 14:18
Forest Hills Lab is filing an IND to initiate a clinical phase 2 study on Parkinson's disease with the US FDA 2021-03-24 12:25
Mindray Releases New Ceiling Supply Unit, Creating a More Optimized ICU Environment 2021-03-24 11:49
CStone Announces New Drug Approval of GAVRETO(R) (pralsetinib) as First Selective RET Inhibitor in China, Providing a New Therapy for a Subset of Non-Small Cell Lung Cancer Patients 2021-03-24 10:46
Adults with obesity treated with semaglutide 2.4 mg achieved and maintained a significant amount of weight loss in a 68-week trial 2021-03-24 04:41
RDIF: Sputnik V approved in Vietnam 2021-03-23 20:45
Pharmactive Earns Acclaim from Frost & Sullivan for Helping People Improve their Cognitive Functions with its Saffron-based Ingredient, Affron® 2021-03-23 20:00
Ortho's VITROS® SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data 2021-03-23 20:00
Pharma Industry to Spend $4.5 Billion on Digital Transformation by 2030 2021-03-23 16:00
Diluent or Immuno-Reagent solutions for your diagnostic testing kits (Covid, Flu, etc.) 2021-03-23 15:04
Taiko Pharmaceutical Officially Launches "Cleverin" in Mexico, Top Made-in-Japan Brand for Removing Viruses/Bacteria, Deodorization 2021-03-23 14:00
Shockwave Announces Joint Venture In China with Genesis MedTech Group 2021-03-23 11:38
CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Hungary 2021-03-23 00:43
PathogenDx Applauded by Frost & Sullivan for Its Ultra-rapid COVID-19 Testing Platform, DetectX-Rv Test 2021-03-22 22:00
Xylonix Reveals New Drug Compound for Combating Cancer and Abnormal Macrophages 2021-03-22 21:00
Sirtex Medical announces new SIR-Spheres(R) DOORwaY-90 Study: The first prospective multicenter U.S.-based trial for registration as first-line treatment for hepatocellular carcinoma 2021-03-22 20:30
Insightful Science Joins Forces with Dotmatics to Form a Leading Cloud-First Scientific R&D Company 2021-03-22 19:03
RedHill Biopharma Announces Compassionate Use Treatment with Opaganib of first COVID-19 Patients in Switzerland 2021-03-22 19:00
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2020 2021-03-22 15:06
Xinhua Silk Road: Nanjing Jiangbei New Area invites global partners to jointly promote dev. of life and health industry 2021-03-22 14:45
1 405 406 407 408 409 790